Rocket's PRV goes for $180M; Oruka targets $500M offering

Article

Rocket's PRV goes for $180M; Oruka targets $500M offering

Source

Rocket sells PRV for $180M: The New Jersey gene therapy maker sold the rare pediatric disease priority review voucher to an undisclosed buyer. Rocket Pharmaceuticals got the PRV after securing FDA ...

Tweets, videos, filings, articles, and source pages tied to this read.

1
endpoints.newsendpoints.news